Department of Community Health Sciences & O'Brien Institute for Public Health, University of Calgary, Calgary, AB, Canada.
Department of Clinical Neurosciences & Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada.
Epilepsia. 2021 Sep;62(9):2094-2102. doi: 10.1111/epi.17012. Epub 2021 Jul 26.
Patient-reported outcome measures (PROMs) are used widely to elicit patient's self-appraisal of their health status and quality of life. One fundamental assumption when measuring PROMs is that all individuals interpret questions about their health status in a consistent manner. However, subgroups of patients with a similar health condition may respond differently to PROM questions (ie, differential item functioning [DIF]), leading to biased estimates of group differences on PROM scores. Understanding these differences can help inform the clinical interpretation of PROMs. This study examined whether DIF affects 10-item Quality of Life in Epilepsy (QOLIE10) scores reported by patients with epilepsy in outpatient clinics.
Data were from the Calgary Comprehensive Epilepsy Program, a prospective registry of patients with epilepsy in Calgary, Alberta. Latent variable mixture models (LVMMs) based on standard two-parameter graded response models with increasing numbers of latent classes were applied to QOLIE10 item data. Model fit was assessed using the Bayesian Information Criterion (BIC) and latent class model entropy. Ordinal logistic regression was used to identify QOLIE10 items that exhibited DIF.
In this cohort of 1143 patients, 567 (49.6%) were female and the median age was 37.0 (interquartile range [IQR] 27.0) years. A two-class LVMM, which provided the best fit to the data, identified two subgroups of patients with different response patterns to QOLIE10 items, with class proportions of 0.62 and 0.38. The two subgroups differed with respect to antiseizure polytherapy, reported medication side effects, frequency of seizures, and psychiatric comorbidities. QOLIE10 items on the physical and psychological side effects of medication exhibited large DIF effects.
Our study revealed two different response patterns to quality-of-life instruments, suggesting heterogeneity in how patients interpret some of the questions. Researchers and users of PROMs in epilepsy need to consider the differential interpretation of items for various instruments to ensure valid understanding and comparisons of PROM scores.
患者报告结局测量(PROM)广泛用于评估患者对自身健康状况和生活质量的自我评估。在测量 PROM 时,一个基本假设是所有个体以一致的方式解释与健康状况相关的问题。然而,具有相似健康状况的患者亚组可能对 PROM 问题的回答不同(即,项目功能差异[DIF]),从而导致 PROM 评分的组间差异的有偏差的估计。了解这些差异可以帮助临床解释 PROM。本研究考察了 DIF 是否影响在门诊就诊的癫痫患者报告的 10 项癫痫生活质量量表(QOLIE10)评分。
数据来自卡尔加里综合癫痫项目(Calgary Comprehensive Epilepsy Program),这是艾伯塔省卡尔加里的一个癫痫患者前瞻性登记处。基于具有递增潜在类别数的标准二参数等级反应模型的潜在变量混合模型(LVMM)被应用于 QOLIE10 项目数据。使用贝叶斯信息准则(BIC)和潜在类别模型熵来评估模型拟合度。有序逻辑回归用于识别表现出 DIF 的 QOLIE10 项目。
在该队列的 1143 名患者中,567 名(49.6%)为女性,中位年龄为 37.0 岁(四分位间距 [IQR] 27.0 岁)。两类别 LVMM 为数据提供了最佳拟合,识别了对 QOLIE10 项目具有不同反应模式的两个患者亚组,类别比例分别为 0.62 和 0.38。这两个亚组在抗癫痫药物多药治疗、报告的药物副作用、癫痫发作频率和精神共病方面存在差异。药物的躯体和心理副作用的 QOLIE10 项目表现出较大的 DIF 效应。
我们的研究揭示了对生活质量量表的两种不同反应模式,表明患者对某些问题的解释存在异质性。癫痫患者中 PROM 的研究人员和使用者需要考虑到各种工具中项目的差异解释,以确保对 PROM 评分的有效理解和比较。